U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Butler M, Urosevic S, Desai P, et al. Treatment for Bipolar Disorder in Adults: A Systematic Review [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Aug. (Comparative Effectiveness Review, No. 208.)

Cover of Treatment for Bipolar Disorder in Adults: A Systematic Review

Treatment for Bipolar Disorder in Adults: A Systematic Review [Internet].

Show details

Appendix PSystematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) Study and Other Psychosocial and Somatic Interventions

Appendix Table P1Characteristics of eligible studies: STEP-BD study and other psychosocial interventions

Study, Year
Design
Location
Funder

Risk of Bias

PMID
Randomized (N)

Age (mean)
Sex (% Female)
Race (% White)
Diagnosis
(% BP I, II, NOS)

Setting
Inclusions

Key Exclusions
Intervention
Description
Comparison
Description
Followup DurationOutcomes
Reported

Withdrawal (%) at endpoint
Depp, 20151
RCT
US
Government

Low

25479050
N=104

Age 48 (22-74)
Female 59%
White 70%
BP I 88%
BP II 12%

Outpatient
Without severe symptoms; Outpatients with BP (DSM-IV) currently prescribed medications for bipolar disorder without severe depressive (MADRS >32) or manic (YMRS> 20)

Substance Abuse; Other Mental Health
Psychoeducation followed by use of a smart phone that delivered interactive elements via a mobile web-based program that delivered questionnaires and responses based on symptoms or early warning signs

-4 sessions of psychoeducation followed by smart intervention (2 surveys per day) for 10 weeks
Psychoeducation followed by binder with paper and pencil mood charts. Monitored remotely via cell phone and had to turn in completed charts at the end of study.

-4 sessions of psychoeducation followed by mood charts once per day for 10 weeks
6 monthsMADRS
YMRS

Withdrawal 22%
Faurholt-Jepsen, 20152
RCT
Denmark
Government and Non-Government

Low

26220802
N=78

Age 29 (18-60)
Female 82%
White NR
BP I 82%

Outpatient
No current clinical state excluded; Individuals with a BP diagnosis (ICD-10 and Schedules for Clinical Assessment in Neuropsychiatry) with a HDRS ≤17 and a YMRS ≤17

Other Mental Health; Pregnant/Nursing; Labs/Other Conditions
Smartphone with self-monitoring system that documented mood, sleep length, activity, medication taken, irritability, cognitive problems, alcohol consumption, stress, menstruation, and early warning signs. Patients could see visual representations of data to self-monitor. System included feedback loop with clinic and contact with study nurse.

-6 months of self-monitoring
Smartphone without self-monitoring system and nurse contact if needed.

-6 months of smart phone access
6 monthsHAMD-17
YMRS
FAST
WHO-Qol-bref

Withdrawal 14%
Deckersbach 20143
Miklowitz 20074
Miklowitz 2007b5
RCT
US
Government and Non-Government

High
Moderate
High

24077657
17728418
17404119
N=293

Age 40 (18-62)
Female 59%
White 91%
BP I 67%
BP II 31%
BP NOS 2%

Outpatient
Major Depressive Episode; BP I or II (DSM-IV) with current major depressive episode (but no mixed episode or depression not otherwise specified), currently being treated with a mood stabilizer (or willing to initiate), not currently undergoing psychotherapy (or willing to discontinue)

Substance Abuse; Other Mental Health; Pregnant/Nursing; Labs/Other Conditions
Intensive psychotherapy consisting of one of the following: 1) individual CBT consisting psychoeducation, life events scheduling, cognitive restructuring, problem-solving, strategies for early detection, and interventions for comorbidities, 2) IPSRT consisting of selecting a primary problem area and teaching patients about the Social Rhythm Metric and interpersonal problem resolution, or 3) family-focused therapy which encouraged patients and relatives to develop a common understanding, develop a relapse prevention plan, participate in communication enhancement exercises, and identify and solve problems related to illness or the home environment.

-30 50-minute sessions over 9 months
Collaborative care consisting of a reviewing a psychoeducational videotape and workbook and developing a treatment contract. Worbook included information about BP, schedule management and mood charting, improving communication skills, an developing a treatment contract.

-Three 50-minute individual sessions
12 monthsRecovery
LIFE-RIFT

Withdrawal 48%

Abbreviations: BP=bipolar disorder; CBT= Cognitive Behavioral Therapy; DSM=Diagnostic and Statistical Manual of Mental Disorders; FAST= Functioning Assessment Short Test; HAMD-17= Hamilton Rating Scale for Depression (17-items); HDRS= Hamilton Depression Rating Scale; ICD-10= International Statistical Classification of Diseases and Related Health Problems- 10th Revision; IPSRT=Interpersonal and Social Rhythm Therapy; LIFE-RIFT= Longitudinal Interval Follow-up Evaluation-Range of Impaired Functioning Tool; MADRS=Montgomery-Asberg Depression Rating Scale; NOS=not otherwise specified; NR=not reported; PMID=PubMed Identification Number; RCT=randomized controlled trial; WHO-QOL-bref= World Health Organization Quality of Life–short version; YMRS = Young Mania Rating Scale

Appendix Table P2Summary risk of bias assessments: STEP-BD study and other psychosocial interventions

Study
Funder
PMID
Overall Risk of Bias
Assessment
Rationale
Depp, 20151
Government
25479050
LowNo significant suspected biases.
Faurholt-Jepsen, 20152
Government and Non-Government
26220802
LowNo significant suspected biases.
Deckersbach 20143
Miklowitz 20074
Miklowitz 2007b5
Government and Non-Government
24077657
17728418
17404119
High
Moderate
High
Suspected bias due to attrition rate of 48%. Part of analysis only includes subset of subjects from total study population.

Abbreviations: PMID=PubMed Identification Number

Appendix Table P3Outcomes summary: STEP-BD Study and other psychosocial interventions

Study
PMID
Responder/RemitterSymptomFunctionOtherAE
Depp, 20151
25479050
NRDepression
6 months, MADRS
NS
ES=0.02; p=0.05

Mania
6 months, YMRS
NS
ES=−0.09;p=0.26
NRNRNR
Faurholt-Jepsen, 20152
26220802
NRDepression
6 months, HAMD-17
NS
Adjusted Difference: 0.96 (95% CI −4.36, 6.28); p=0.72
Mania
6 months, YMRS
NS
Adjusted Difference= −0.34 (95% CI −1.14, 0.47); p=0.41
Global Function
6 months, FAST
NS
Adjusted Difference= 0.96 (95% CI −4.36, 6.28); p=0.72

Quality of Life
NS
6 months, WHO-QOL-bref
Adjusted Difference= 1.24 (95% CI −5.18, 2.70); p=0.54
NRNR
Deckersbach 20143
24077657

Miklowitz 20074
17728418

Miklowitz 2007b5
17404119
Number Recovered
1 year
Favors intensive psychosocial intervention
HR 1.47; p = .01
Family Therapy: HR 1.87
IPSRT: HR 1.48
CBT: HR 1.34
NRFunctional Impairement
9 months, LIFT-RIFT
Favors intensive psychosocial intervention, p=0.04

Mean Difference (SD)
Family Therapy: −3.17 (3.06)
IPSRT: −1.63 (4.35)
CBT: −1.05 (4.77)
Collaborative Care: −0.94 (3.5)
NRNR

Abbreviations: AE=Adverse Events; CBT= Cognitive Behavioral Theraphy; CI=Confidence Interval; ES=Effect Size; FAST= Functioning Assessment Short Test; HAMD-17= Hamilton Rating Scale for Depression (17-items); HR=Hazard Ratio; LIFE-RIFT= Longitudinal Interval Follow-up Evaluation-Range of Impaired Functioning Tool; MADRS=Montgomery-Asberg Depression Rating Scale; IPSRT= Interpersonal and Social Rhythm Therapy; NR=not reported; NS=not significant; PMID=PubMed Identification Number; SD=standard deviation; WHO-QOL-bref= World Health Organization Quality of Life–short version; YMRS = Young Mania Rating Scale

Appendix Table P4Summary of strength of evidence: other psychosocial interventions, self-management interventions

OutcomeTiming# Studies/Design
(n analyzed)
Finding or
Summary
Statistic
Study
Limitations
ConsistencyDirectnessPrecisionOverall Grade/Conclusion
RelapseNR-------
Depression6 months2 RCTs (n=182)No difference between groups in MADRS at 6 months.LowConsistentDirectImpreciseInsufficient
Mania6 months2 RCTs (n=182)No difference between groups in YMRS at 6 months.LowConsistentDirectImpreciseInsufficient
Global Function6 months1 RCT (n=78)No difference between groups at 6 months.

FAST
Adjusted Difference= 0.96 (95% CI −4.36, 6.28); p=0.72
LowUnclearDirectImpreciseInsufficient
Other Measures of Function6 months1 RCT (n=78)No difference between groups at 6 months.

WHO-QOL-bref
Adjusted Difference= 1.24 (95% CI −5.18, 2.70); p=0.54
LowUnclearDirectImpreciseInsufficient

Abbreviations: CI=Confidence Interval; FAST= Functioning Assessment Short Test; MADRS=Montgomery-Asberg Depression Rating Scale; NR=not reported; RCT=randomized controlled trial; WHO-QOL-bref= World Health Organization Quality of Life–short version; YMRS = Young Mania Rating Scale

Appendix Table P5Characteristics of eligible studies: somatic therapy

Study, Year
Design
Location
Funder

Risk of Bias

PMID
Randomized (N)

Age (mean)
Sex (% Female)
Race (% White)
Diagnosis
(% BP I, II, NOS)

Setting
Inclusions

Key Exclusions
Intervention
Description
Comparison
Description
Follow-up DurationOutcomes
Reported

Withdrawal (%) at endpoint
Fitzgerald, 20166
RCT
Australia
Government

Medium

27016659
N = 46
Age 46 (33-59)
Female 57%
Race NR
BP I 63%
BP II 37%

Outpatient
Depression; Individuals with BP I or II (DSM-IV) with persistent depressive symptoms (HAM-D > 20) who failed to respond to at least two courses of anti-depressants for at least 6 weeks in current episode. No increase or initiation of new treatment in the four weeks prior to rTMS.

Labs/Other Conditions; Neurological Disorder
Repetitive transcranial magnetic stimulation

-20 rTMS sessions for four weeks
Sham stimulation

-20 sham sessions for four weeks
4 weeksHAM-D
Response
Remission (Not Defined)

Withdrawal 13%

Abbreviations: BP=bipolar disorder; CBT= Cognitive Behavioral Therapy; DSM=Diagnostic and Statistical Manual of Mental Disorders; FAST= Functioning Assessment Short Test; HAMD-17= Hamilton Rating Scale for Depression (17-items); HDRS= Hamilton Depression Rating Scale; ICD-10= International Statistical Classification of Diseases and Related Health Problems- 10th Revision; IPSRT=Interpersonal and Social Rhythm Therapy; LIFE-RIFT= Longitudinal Interval Follow-up Evaluation-Range of Impaired Functioning Tool; MADRS=Montgomery-Asberg Depression Rating Scale; NOS=not otherwise specified; NR=not reported; PMID=PubMed Identification Number; RCT=randomized controlled trial; WHO-QOL-bref= World Health Organization Quality of Life–short version; YMRS = Young Mania Rating Scale

Appendix Table P6Summary risk of bias assessments: somatic therapy

Study
Funder
PMID
Overall Risk of Bias AssessmentRationale
Fitzgerald, 20166
Government
27016659
ModerateSuspected bias due to unclear reporting of attrition/loss to followup.

Abbreviations: PMID=PubMed Identification Number

Appendix Table P7Outcomes summary: somatic therapy

Study
PMID
Responder/RemitterSymptomFunctionOtherAE
Fitzgerald, 20166
27016659
Response
4 weeks
NS; p<0.05
rTMS=3
Sham=1

Remission
4 weeks
NS; p<0.05
rTMS=2
Sham=0
Depression*
4 weeks, HAM-D
NS
ES=−0.04 (95% CI −0.62, 0.54)
NRNRNR

Abbreviations: AE=Adverse Events; CI=Confidence Interval; ES=Effect Size;

References for Appendix P

1.
Depp CA, Ceglowski J, Wang VC, et al Augmenting psychoeducation with a mobile intervention for bipolar disorder: a randomized controlled trial. Journal of Affective Disorders. 2015 Mar 15;174:23–30. doi: http://dx​.doi.org/10​.1016/j.jad.2014.10.053. PMID: 25479050. [PMC free article: PMC4339469] [PubMed: 25479050]
2.
Faurholt-Jepsen M, Frost M, Ritz C, et al Daily electronic self-monitoring in bipolar disorder using smartphones - the MONARCA I trial: a randomized, placebo-controlled, single-blind, parallel group trial. Psychological Medicine. 2015 Oct;45(13):2691–704. doi: http://dx​.doi.org/10​.1017/S0033291715000410. PMID: 26220802. [PubMed: 26220802]
3.
Deckersbach T, Peters AT, Sylvia L, et al Do comorbid anxiety disorders moderate the effects of psychotherapy for bipolar disorder? Results from STEP-BD. American Journal of Psychiatry. 2014 Feb;171(2):178–86. doi: http://dx​.doi.org/10​.1176/appi.ajp.2013.13020225. PMID: 24077657. [PMC free article: PMC3946300] [PubMed: 24077657]
4.
Miklowitz DJ, Otto MW, Frank E, et al Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial. American Journal of Psychiatry. 2007 Sep;164(9):1340–7. PMID: 17728418. [PMC free article: PMC3579578] [PubMed: 17728418]
5.
Miklowitz DJ, Otto MW, Frank E, et al Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program. Archives of General Psychiatry. 2007 Apr;64(4):419–26. PMID: 17404119. [PMC free article: PMC3579612] [PubMed: 17404119]
6.
Fitzgerald PB, Hoy KE, Elliot D, et al A negative double-blind controlled trial of sequential bilateral rTMS in the treatment of bipolar depression. Journal of Affective Disorders. 2016 01 Jul;198:158–62. doi: http://dx​.doi.org/10​.1016/j.jad.2016.03.052. PMID: 27016659 PMID/609157504 Embase. [PubMed: 27016659]

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (15M)

Other titles in this collection

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...